Sleep Number Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Sales Results. Also, Piper Sandler Maintained a Neutral Rating on the Stock and Lowered Its Price Target From $13 to $12.
Sleep Number Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Sales Results. Also, Piper Sandler Maintained a Neutral Rating on the Stock and Lowered Its Price Target From $13 to $12.
sleep number股票報告Q2銷售業績不如預期，交易價格下跌。此外，派傑投資對股票保持中立評級，並將其價格目標從13美元下調至12美元。
Sleep Number Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Sales Results. Also, Piper Sandler Maintained a Neutral Rating on the Stock and Lowered Its Price Target From $13 to $12.
sleep number股票報告Q2銷售業績不如預期，交易價格下跌。此外，派傑投資對股票保持中立評級，並將其價格目標從13美元下調至12美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。